|
|
Publication Personal Formatting |
|
Simplified urinary steroid profiling by LC-MS as diagnostic tool for malignancy in adrenocortical tumors. Vogg N, Müller T, Floren A, Dandekar T, Riester A, Dischinger U, Kurlbaum M, Kroiss M, Fassnacht M. Clin Chim Acta. 2023 Mar 15;543:117301. doi: 10.1016/j.cca.2023.117301. Epub 2023 Mar 21.
|
|
Targeted metabolic profiling of urinary steroids with a focus on analytical accuracy and sample stability. Vogg N, Müller T, Floren A, Dandekar T, Scherf-Clavel O, Fassnacht M, Kroiss M, Kurlbaum M. J Mass Spectrom Adv Clin Lab. 2022 Jul 25;25:44-52. doi: 10.1016/j.jmsacl.2022.07.006. eCollection 2022
|
|
Method-Specific Cortisol and Dexamethasone Thresholds Increase Clinical Specificity of the Dexamethasone Suppression Test for Cushing Syndrome. Vogg N, Kurlbaum M, Deutschbein T, Gräsl B, Fassnacht M, Kroiss M. Clin Chem. 2021 Jul 6;67(7):998-1007. doi: 10.1093/clinchem/hvab056.
|
|
Steroid sulfation in adrenal tumors. Mueller JW, Vogg N, Lightning TA, Weigand I, Ronchi CL, Foster PA, Kroiss M. J Clin Endocrinol Metab. 2021 Mar 19:dgab182. doi: 10.1210/clinem/dgab182. Online ahead of print.
|
|
|